Investigating Up-to-Seven Criteria and APRI (AST Platelet Ratio) as Prognostic Factors in Intermediate-Stage Hepatocellular Carcinoma Patients Who Received Transarterial Chemoembolization.

Inmutto, Nakarin; Nimitrungtawee, Natthaphong; Srisuwan, Tanop; Kattipathanapong, Thanate; Jantarangkoon, Attaporn; Puttisri, Oranit

Inmutto, Nakarin; Nimitrungtawee, Natthaphong; Srisuwan, Tanop; Kattipathanapong, Thanate; Jantarangkoon, Attaporn; Puttisri, Oranit.

Afiliação

Inmutto N; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Nimitrungtawee N; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Srisuwan T; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Kattipathanapong T; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Jantarangkoon A; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Puttisri O; Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Asian Pac J Cancer Prev ; 23(11): 3939-3946, 2022 Nov 01.

Article em En | MEDLINE | ID: mdl-36444608

Assuntos

Carcinoma Hepatocelular; Quimioembolização Terapêutica; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/terapia; Prognóstico; Neoplasias Hepáticas/terapia; Plaquetas

Palavras-chave

Computed tomography imaging; Hepatocellular carcinoma; Intermediate stage; survival outcomes; transarterial chemoembolization

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google